Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers and is the third leading cause of cancer-related mortality worldwide. Multifactorial drug resistance is regarded as the major cause of treatment failure in HCC. Accumulating evidence shows that the constituents of the...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-11-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.988956/full |
| _version_ | 1798018888182530048 |
|---|---|
| author | Jiaxin Zhang Huiqiong Han Lei Wang Wenjia Wang Mei Yang Yanru Qin |
| author_facet | Jiaxin Zhang Huiqiong Han Lei Wang Wenjia Wang Mei Yang Yanru Qin |
| author_sort | Jiaxin Zhang |
| collection | DOAJ |
| description | Hepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers and is the third leading cause of cancer-related mortality worldwide. Multifactorial drug resistance is regarded as the major cause of treatment failure in HCC. Accumulating evidence shows that the constituents of the tumor microenvironment (TME), including cancer-associated fibroblasts, tumor vasculature, immune cells, physical factors, cytokines, and exosomes may explain the therapeutic resistance mechanisms in HCC. In recent years, anti-angiogenic drugs and immune checkpoint inhibitors have shown satisfactory results in HCC patients. However, due to enhanced communication between the tumor and TME, the effect of heterogeneity of the microenvironment on therapeutic resistance is particularly complicated, which suggests a more challenging research direction. In addition, it has been reported that the three-dimensional (3D) organoid model derived from patient biopsies is more intuitive to fully understand the role of the TME in acquired resistance. Therefore, in this review, we have focused not only on the mechanisms and targets of therapeutic resistance related to the contents of the TME in HCC but also provide a comprehensive description of 3D models and how they contribute to the exploration of HCC therapies. |
| first_indexed | 2024-04-11T16:31:37Z |
| format | Article |
| id | doaj.art-94298e07d33346be95e1b6e9031927c3 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-04-11T16:31:37Z |
| publishDate | 2022-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-94298e07d33346be95e1b6e9031927c32022-12-22T04:14:01ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-11-011210.3389/fonc.2022.988956988956Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironmentJiaxin ZhangHuiqiong HanLei WangWenjia WangMei YangYanru QinHepatocellular carcinoma (HCC) accounts for the majority of primary liver cancers and is the third leading cause of cancer-related mortality worldwide. Multifactorial drug resistance is regarded as the major cause of treatment failure in HCC. Accumulating evidence shows that the constituents of the tumor microenvironment (TME), including cancer-associated fibroblasts, tumor vasculature, immune cells, physical factors, cytokines, and exosomes may explain the therapeutic resistance mechanisms in HCC. In recent years, anti-angiogenic drugs and immune checkpoint inhibitors have shown satisfactory results in HCC patients. However, due to enhanced communication between the tumor and TME, the effect of heterogeneity of the microenvironment on therapeutic resistance is particularly complicated, which suggests a more challenging research direction. In addition, it has been reported that the three-dimensional (3D) organoid model derived from patient biopsies is more intuitive to fully understand the role of the TME in acquired resistance. Therefore, in this review, we have focused not only on the mechanisms and targets of therapeutic resistance related to the contents of the TME in HCC but also provide a comprehensive description of 3D models and how they contribute to the exploration of HCC therapies.https://www.frontiersin.org/articles/10.3389/fonc.2022.988956/fullhepatocellular carcinomatumor microenvironmenttherapeutic resistancetherapeutic targetsnovel drugspatient-derived organoids |
| spellingShingle | Jiaxin Zhang Huiqiong Han Lei Wang Wenjia Wang Mei Yang Yanru Qin Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment Frontiers in Oncology hepatocellular carcinoma tumor microenvironment therapeutic resistance therapeutic targets novel drugs patient-derived organoids |
| title | Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment |
| title_full | Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment |
| title_fullStr | Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment |
| title_full_unstemmed | Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment |
| title_short | Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment |
| title_sort | overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment |
| topic | hepatocellular carcinoma tumor microenvironment therapeutic resistance therapeutic targets novel drugs patient-derived organoids |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2022.988956/full |
| work_keys_str_mv | AT jiaxinzhang overcomingthetherapeuticresistanceofhepatomasbytargetingthetumormicroenvironment AT huiqionghan overcomingthetherapeuticresistanceofhepatomasbytargetingthetumormicroenvironment AT leiwang overcomingthetherapeuticresistanceofhepatomasbytargetingthetumormicroenvironment AT wenjiawang overcomingthetherapeuticresistanceofhepatomasbytargetingthetumormicroenvironment AT meiyang overcomingthetherapeuticresistanceofhepatomasbytargetingthetumormicroenvironment AT yanruqin overcomingthetherapeuticresistanceofhepatomasbytargetingthetumormicroenvironment |